Structural studies of cord factors from Mycobacterium simiae related to the capacity for tumour necrosis factor alpha (α-TNF) induction

Microbiology

Volumn 156, Issue 12, 2010, Pages 3744-3753

  Mederos, Lilian M ^a   Montoro, Ernesto H ^a   Bernabéu, Antonia ^b   Linares, Carlos ^b   Valero Guillén, Pedro L ^b  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA MYCOLIC ACID; CARBON; CORD FACTOR; CYCLOPROPANE; CYTOKINE; HYDROXY FATTY ACID; MONOUNSATURATED FATTY ACID; MYCOLIC ACID; OXOMYCOLIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATOM; BACTERIAL STRAIN; CELL LINE; CYTOKINE RELEASE; FATTY ACID ANALYSIS; IMMUNOGENICITY; MACROPHAGE; MASS SPECTROMETRY; MYCOBACTERIUM SIMIAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALS; CELL LINE; CORD FACTORS; HUMANS; MICE; MOLECULAR STRUCTURE; MYCOBACTERIUM; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

MYCOBACTERIUM SIMIAE;

EID: 78650045282     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.042077-0     Document Type: Article

References (54)

1. Bhatt, A., Fujiwara, N., Bhatt, K., Gurcha, S. S., Kremer, L., Cheng, B., Chan, J., Porcelli, S. A., Kobayashi, K. & other authors (2007). Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice. Proc Natl Acad Sci U S A 104, 5157-5162.
2. Bloch, H. (1950). Studies on the virulence of tubercle bacilli. Isolation and biological properties of a constituent of virulent organisms. J Exp Med 91, 197-218.
3. Bowdish, D. M. E., Sakamoto, K., Kim, M.-J., Mariliis Kroos, M., Mukhopadhyay, S., Leifer, C. A., Tryggvason, K., Gordon, S. & Russell, D. G. (2009). MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog 5, e1000474.
4. Brennan, P. J. & Nikaido, H. (1995). The envelope of mycobacteria. Annu Rev Biochem 64, 29-63.
5. Cooper, A. M. (2009). Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27, 393-422.
6. Daffé, M. & Draper, P. (1998). The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 39, 131-203. (Pubitemid 29077883)
7. Dao, D. N., Sweeney, K., Hsu, T., Gurcha, S. S., Nascimento, I. P., Roshevsky, D., Besra, G., Chan, J., Porcelli, S. A. & Jacobs, W. R., Jr (2008). Mycolic acid modification by mmaA4 gene of M. tuberculosis modulates IL-12 production. PLoS Pathog 4, e1000081.
8. Dietrich, J. & Doherty, T. M. (2009). Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development. APMIS 117, 440-457.
9. Divya Jyothi, M., Garg, S. K. & Singh, N. B. (2000). Mechanisms involved in protective immune response generated by secretory proteins of Mycobacterium habana against experimental tuberculosis. Scand J Immunol 51, 502-510.
10. Dubnau, E., Chan, J., Raynaud, C., Mohan, V. P., Laneélle, M. A., Yu, K., Quémard, A., Smith, I. & Daffé, M. (2000). Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol Microbiol 36, 630-637.
11. Falkinham, J. O., III (1996). Epidemiology of infection by non-tuberculous mycobacteria. Clin Microbiol Rev 9, 177-215.
12. Fujita, Y., Naka, T., McNeil, M. R. & Yano, I. (2005). Intact molecular characterization of cord factor (trehalose 6,6′-dimycolate) from nine species of mycobacteria by MALDI-TOF mass spectrometry. Microbiology 151, 3403-3416. (Pubitemid 41488922)
13. Fujita, Y., Okamoto, Y., Uenishi, Y., Sunagawa, M., Uchiyama, T. & Yano, I. (2007). Molecular and supramolecular structure related differences in toxicity and granulomatogenic activity of mycobacterial cord factor in mice. Microb Pathog 43, 10-21.
14. Glickman, M. S., Cox, J. S. & Jacobs, W. R., Jr (2000). A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol Cell 5, 717-727.
15. Gupta, H. P., Singh, N. B., Mathur, I. S. & Gupta, S. K. (1979). Mycobacterium habana, a new immunogenic strain in experimental tuberculosis. Indian J Exp Biol 17, 1190-1193.
16. Hayashi, D., Takii, T., Fujiwara, N., Fujita, Y., Yano, I., Yamamoto, S., Kondo, M., Inagaki, M., Yasuda, E. & other authors (2009). Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis Bacillus Calmette-Guérin (BCG) substrains. FEMS Immunol Med Microbiol 56, 116-128.
17. Hunter, R. L., Olsen, M. R., Jagannath, C. & Actor, J. K. (2006). Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease. Ann Clin Lab Sci 36, 371-386.
18. Hunter, R. L., Armitige, L., Jagannath, C. & Actor, J. K. (2009). TB research at UT-Houston. A review of cord factor: new approaches to drugs, vaccines and the pathogenesis of tuberculosis. Tuberculosis (Edinb) 89, S18-S25.
19. Ishikawa, E., Ishikawa, T., Morita, Y. S., Toyonaga, K., Yamada, H., Takeuchi, O., Kinoshita, T., Akira, S., Yoshikai, Y. & Yamashaki, S. (2009). Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med 206, 2879-2888.
20. Khoo, K. H., Chaterjee, D., Dell, A., Morris, H. R., Brennan, P. J. & Draper, P. (1996). Novel O-methylated terminal glucuronic acid characterizes the polar glycopeptidolipids of Mycobacterium habana TMC 5135. J Biol Chem 271, 12333-12342.
21. Lin, F. L., van Halbeek, H. & Bertozzi, C. R. (2007). Synthesis of mono- and dideoxygenated a,a-trehalose analogs. Carbohydr Res 342, 2014-2030.
22. McNeil, M., Daffé, M. & Brennan, P. J. (1991). Location of mycoloyl ester substituents in the cell walls of mycobacteria. J Biol Chem 266, 13217-13223.
23. Mederos, L. M., Gutiérrez, A. M. & Valdivia, J. A. (1992). Utilization of a new culture medium in biochemical tests for the mycobacterial classification. Mem Inst Oswaldo Cruz 87, 441.
24. Mederos, L. M., Valdivia, J. A. & Valero-Guillén, P. L. (1998). Analysis of lipids reveals differences between 'Mycobacterium habana' and Mycobacterium simiae. Microbiology 144, 1181-1188.
25. Mederos, L. M., Valdivia, J. A. & Valero-Guillén, P. L. (2006). Lipids of 'Mycobacterium habana', a synonym of Mycobacterium simiae with vaccine potential. Tuberculosis (Edinb) 86, 324-329.
26. Mederos, L., Valdivia, J. A. & Valero-Guillén, P. L. (2007). Analysis of the structure of mycolic acids of Mycobacterium simiae reveals a particular composition of α-mycolates in strain 'habana' TMC 5135, considered as immunogenic in tuberculosis and leprosy. Microbiology 153, 4159-4165.
27. Mederos, L., Valdivia, J. A. & Valero-Guillén, P. L. (2008). New variants of polar glycopeptidolipids detected in Mycobacterium simiae, including 'habana' strains, as evidenced by electrospray ionizationion trap-mass spectrometry. J Appl Microbiol 105, 602-614.
28. Minnikin, D. E. (1982). Lipids: complex lipids. In The Biology of the Mycobacteria, vol. 1, pp. 95-184. Edited by C. Ratledge & J. L. Stanford. London: Academic Press.
29. Minnikin, D. E. & Goodfellow, M. (1976). Lipid composition in the classification and identification of nocardiae and related taxa. In The Biology of the Nocardiae, pp. 160-219. Edited by M. Goodfellow, G. H. Brownell & J. A. Serrano. London: Academic Press.
30. Niescher, S., Wray, V., Lang, S., Kaschabek, S. R. & Schlömann, M. (2006). Identification and structural characterisation of novel trehalose dinocardomycolates from n-alkane-grown Rhodococcus opacus 1CP. Appl Microbiol Biotechnol 70, 605-611.
31. Nishizawa, M., Yamamoto, H., Imagawa, H., Barbier-Chassafière, V., Petit, M., Azuma, I. & Papy-García, D. (2007). Efficient synthesis of a series of trehalose dimycolate (TDM)/trehalose dicorynemycolate (TDCM) analogues and their interleukin-6 level enhancement activity in mice sera. J Org Chem 72, 1627-1633.
32. Noll, H., Bloch, H., Asselineau, J. & Lederer, E. (1956). The chemical structure of the cord factor of Mycobacterium tuberculosis. Biochim Biophys Acta 20, 299-309.
33. Ozeki, Y., Tsutsui, H., Kawada, N., Suzuki, H., Kataoka, M., Kodama, T., Yano, I., Kaneda, K. & Kobayashi, K. (2006). Macrophage scavenger receptor down-regulates mycobacterial cord factor-induced proinflammatory cytokine production by alveolar and hepatic macrophages. Microb Pathog 40, 171-176.
34. Quémard, A., Lanéelle, M. A., Marrackhi, H., Promé, D., Dubnau, E. & Daffé, M. (1997). Structure of a hydroxymycolic acid potentially involved in the synthesis of oxygenated mycolic acids of Mycobacterium tuberculosis complex. Eur J Biochem 250, 758-763.
35. Rao, V., Fujiwara, N., Porcelli, S. A. & Glickman, M. S. (2005). Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J Exp Med 201, 535-543.
36. Rao, V., Gao, F., Chen, B., Jacobs, W. R., Jr & Glickman, M. S. (2006). Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis-induced inflammation and virulence. J Clin Invest 116, 1660-1667.
37. Rhoades, E., Hsu, F. F., Torrelles, J. B., Turk, J., Chaterjee, D. & Russell, D. G. (2003). Identification and macrophage-activating activity of glycolipids released from intracellular Mycobacterium bovis BCG. Mol Microbiol 48, 875-888.
38. Riley, L. W. (2006). Of mice, men, and elephants: Mycobacterium tuberculosis cell envelope and pathogenesis. J Clin Invest 116, 1475-1478.
39. Schroeder, B. G. & Barry, C. E. (2001). The specificity of methyl transferases involved in transmycolic acid biosynthesis in Mycobacterium tuberculosis and Mycobacterium smegmatis. Bioorg Chem 29, 164-177.
40. Silva, C. L., Tincani, I., Brandao-Filho, S. L. & Faccioli, L. H. (1988). Mouse cachexia induced by trehalose dimycolate from Nocardia asteroides. J Gen Microbiol 134, 1629-1633.
41. Singh, N. B., Lowe, C. R. E., Rees, R. J. W. & Colston, M. J. (1989). Vaccination of mice against Mycobacterium leprae infection. Infect Immun 57, 653-655.
42. Singh, N. B., Gupta, H. P., Srivastava, A., Kandpal, H. & Srivastava, U. M. (1997). Lymphostimulatory and delayed-type hypersensitivity responses to a candidate leprosy vaccine strain: Mycobacterium habana. Lepr Rev 68, 125-130.
43. Takayama, K., Wang, C. & Besra, G. S. (2005). Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin Microbiol Rev 18, 81-101.
44. Takimoto, H., Maruyama, H., Shimada, K.-L., Yakabe, R., Yano, I. & Kumazawa, Y. (2006). Interferon-γ independent formation of pulmonary granuloma in mice by injections with trehalose dimycolate (cord factor), lipoarabinomannan and phosphatidylinositol mannosides isolated from Mycobacterium tuberculosis. Clin Exp Immunol 144, 134-141.
45. Ueda, S., Fujiwara, N., Naka, T., Sakaguchi, I., Ozeki, Y., Yano, I., Kasama, T. & Kobayashi, K. (2001). Structure-activity relationship of mycoloyl glycolipids derived from Rhodococcus sp. 4306. Microb Pathog 30, 91-99.
46. Valdivia, J. A. (1973). Mycobacterium habana: clinical and epidemiological significance. Ann Soc Belg Med Trop 53, 263-266.
47. Villeneuve, M., Kawai, M., Watanabe, M., Aoyagi, I., Hitotsuyanagi, Y., Takeya, K., Gouda, H., Hirono, S., Minnikin, D. E. & Nakahara, H. (2007). Conformational behavior of oxygenated mycobacterial mycolic acids from Mycobacterium bovis BCG. Biochim Biophys Acta 1768, 1717-1726.
48. Villeneuve, M., Kawai, M., Watanabe, M., Aoyagi, I., Hitotsuyanagi, Y., Takeya, K., Gouda, H., Hirono, S., Minnikin, D. E. & Nakahara, H. (2010). Differential conformational behaviors of α-mycolic acids in Langmuir monolayers and computer simulation. Chem Phys Lipids 163, 569-579.
49. Watanabe, M., Ohta, A., Sasaki, A. & Minnikin, D. E. (1999). Structure of a new glycolipid from the Mycobacterium avium-Mycobacterium intracellulare complex. J Bacteriol 181, 2293-2297.
50. Watanabe, M., Aoyagi, Y., Ridell, M. & Minnikin, D. E. (2001). Separation and characterization of individual mycolic acids in representative mycobacteria. Microbiology 147, 1825-1837. (Pubitemid 32684925)
51. Watanabe, M., Aoyagi, Y., Mitome, H., Fujita, T., Naoki, H., Ridell, M. & Minnikin, D. E. (2002). Location of functional groups in mycobacterial meromycolate chains; the recognition of new structural principles in mycolic acids. Microbiology 148, 1881-1902.
52. Weiszfeiler, J. G. & Karczag, E. (1976). Synonymy of Mycobacterium simiae Karasseva et al. 1965 and Mycobacterium habana Valdivia et al. 1971. Int J Syst Bacteriol 26, 474-477.
53. Welsh, K. J., Abbott, A. N., Hwang, S.-A., Indrigo, J., Armitige, L. Y., Blackburn, M. R., Hunter, R. L., Jr & Actor, J. K. (2008). A role for tumour necrosis factor-α, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6′-dimycolate induced granulomatous response. Microbiology 154, 1813-1824.
54. Werninghaus, K., Babiak, A., Groß, O., Hölscher, C., Dietrich, H., Agger, E. M., Mages, J., Mocsai, A., Schoenen, H. & other authors (2009). Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ-Syk-Card9- dependent innate immune activation. J Exp Med 206, 89-97.